High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection
US8940298B2 · kind B2 · utility
11Cited by
259References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 4, 2008 |
| Grant date | Jan 27, 2015 |
| Priority date | — |
| Expiry date | Mar 1, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/57492
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel high affinity antibodies and fragments thereof that bind to the cancer antigen PSCA. The antibodies of the present invention may be used for cancer diagnosis, prognosis, treatment, visualization, and the like. The present invention also provides methods for the detection, visualization, and treatment of various cancers expressing PSCA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.